What does the product information say about using Scheriproct Ointment during the first trimester of pregnancy?

Scheriproct Ointment should generally be avoided in the first trimester because safety evidence is inadequate and oral-cleft risk may increase; benefits must be weighed against risks and prolonged use avoided, although essential corticosteroids may be used as in non-pregnant patients with normal pregnancies, while pre-eclampsia or fluid retention requires close monitoring.